World’s first drug to target untreatable and deadly ‘sticky’ cholesterol ...Middle East

Bloomberg News Today - News
World’s first drug to target untreatable and deadly ‘sticky’ cholesterol
The first human trial led by Monash University in Australia demonstrated the success of Muvalaplin. The first oral drug ever developed to target Lp(a) effectively lowered its levels by up to 65 per cent. It works by disrupting the ability for Lp(a) to form in the body. The findings were presented at the European Society of Cardiology Congress in Amsterdam and also published in JAMA. “This drug is a gamechanger in more ways than one. Not only do we have an option for lowering an elusive form of cholesterol, but being able to deliver it in an oral tablet means it will be more accessible for patients,” said study lead Professor Stephen Nicholls, Director of the Monash University’s Victo

Hence then, the article about world s first drug to target untreatable and deadly sticky cholesterol was published today ( ) and is available on Bloomberg News Today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( World’s first drug to target untreatable and deadly ‘sticky’ cholesterol )

Apple Storegoogle play

Last updated :

Also on site :